Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

This case report describes a successful outcome involving a patient with severe COVID-19 viral pneumonia utilizing a novel therapeutic approach with the glycoprotein IIb/IIIa inhibitor, eptifibatide.


Patrick Joseph Merrill, R Mark Bradburne. Successful Use of Glycoprotein IIb/IIIa Inhibitor Involving Severely Ill COVID-19 Patient. The Permanente journal. 2021 Dec 14;25

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 35348110

View Full Text